Skip to content

Synergus RWE is now part of athagoras Medtech. For current services and contact, visit medtech.athagoras.com

Go to athagoras Medtech
Synergus RWE
← Archived pages

NIHR - Government collaboration with industry regarding clinical trials

This webinar will describe how the National Institute for Health Research (NIHR) works in partnership with medical device and diagnostics companies to help them successfully translate ideas into innovative medical technologies for use in the UK's National Health Service (NHS). Presenters will signpost to funding opportunities that exist in the UK and explain how you can engage experts from NHS and universities to help you throughout all stages of product development: from identifying unmet clinical needs to designing and running clinical studies. The webinar will also showcase the NIHR Study Support Service - a free of charge service designed to support companies and Contract Research Organisations to plan, set up and deliver high quality research to time and target in the NHS in England. The services benefits include: national level and site level feasibility assessments; streamlined site identification; quicker costing and contracts; rapid recruitment; and proactive performance management.

Speakers:

  • Theo Christie is a Business Development Manager (Commercial) for the NIHR Clinical Research Network (CRN). Theo facilitates key discussions between industry and the Clinical Research Network and is a point of contact for the life sciences companies engaging with the Clinical Research Network. Theo is able to provide advice to companies on how they are able to tap into the Clinical Research Network study support services to ensure clinical studies are set up effi ciently and recruit to time and target. With a degree in Clinical Sciences, Theo has been with the Clinical Research Network since 2013. Before joining the Business Development and Marketing Team, Theo previously worked within the Research Delivery Directorate of the Clinical Research Network. He was responsible for supporting interactions between the life sciences industry and NIHR National Specialty Groups across 10 therapeutic areas, providing operational support through feasibility, set up and patient recruitment.
     
  • Dr Caterina Lombardo - Caterina is Senior Programme Manager in the Invention for Innovation (i4i) team, working on scoping for new calls, as well as commissioning and monitoring of funding attributed to Medtech innovations that have the potential of being game changers in the health and care of patients. Prior to this, she was the programme manager dedicated to the NIHR Clinical Research Facilities for the NIHR Infrastructure team.
    Caterina obtained her PhD in Medicinal Chemistry from the School of Pharmacy - University of London (now UCL), and worked as a researcher developing new drugs and biotechnologies in both the UK and France. She then worked as central monitor assistant for multicentre clinical trials in a multinational contract research organisation. These experiences allowed Caterina to have a broad overview of processes and problems related to the development of new ideas from bench to bedside.
     
  • Dr Peter SargentIan, Head of Business Development

    Dr Peter Sargent is the Head of Business Development for NOCRI where he leads a team supporting life science companies globally gain access to expertise, facilities and funding from across the NIHR and wider UK health System. His team also works closely with the Department of Health and Social Care, Office for Life Sciences and the Department of International Trade to promote the UK across the globe.

    Following obtaining his PhD in Molecular Biology and Biochemistry from King’s College London, Peter has worked with in a variety of In Vitro Diagnostic and Drug Development companies at senior management level, leading R&D and Business Development functions in the development and commercialisation of healthcare products and services. Now working for the NIHR, he utilises his industry experience to support companies in their product development with the aim to bring new technologies and therapies into the NHS.